The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, December 07, 2020
Glycostem Therapeutics announced the opening of a phase I/IIa trial for its lead product oNKord for the treatment of AML patients.
read more
Monday, December 07, 2020
RedHill Biopharma has initiated its Phase 3 study to evaluate the safety and efficacy of RHB-204 as a potential first-line, stand-alone, oral ...
read more
Monday, December 07, 2020
Eiger announced the FDA has approved Zokinvy for the treatment of Hutchinson-Gilford Progeria Syndrome and processing-deficient Progeroid ...
read more
Tuesday, December 08, 2020
Sotira has announced the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, ...
read more
Tuesday, December 08, 2020
ARCA biopharma announced the FDA has designated as a Fast Track development program the investigation of AB201 as a potential treatment for COVID-19.
read more
Tuesday, December 08, 2020
MapLight Therapeutics has completed dosing of healthy volunteers across five cohorts in a Phase 1 clinical trial evaluating the safety of ML-004, a ...
read more
Tuesday, December 08, 2020
Neurelis has concluded a pre-IND Application meeting with the FDA regarding NRL-4.
read more
Tuesday, December 08, 2020
Metabolon will participate in the NIAID, part of the National Institutes of Health, Immunophenotyping Assessment in a COVID-19 Cohort.
read more
Wednesday, December 09, 2020
Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes after 40 weeks of treatment in topline results...
read more
Wednesday, December 09, 2020
AbbVie announced positive results from the Phase 3 induction study which showed upadacitinib met the primary endpoint of clinical remission at week 8,...
read more
Thursday, December 10, 2020
Oramed has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes.
read more
Thursday, December 10, 2020
The FDA approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1, a rare genetic disorder.
read more
Thursday, December 10, 2020
PhoenixMD announced the first patient has been dosed in their Phase 1b clinical trial of PMD-026.
read more
Friday, December 11, 2020
Following yesterday’s positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the FDA has informed the sponsor ...
read more
Friday, December 11, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more